Propiedad y actividad de insiders de Black Diamond Therapeutics, Inc. (BDTX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.94 |
| Capitalización | $111M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-26 | Behbahani Ali | A-Award | 40,000 | $68K |
| 2026-06-26 | Kulkarni Samarth | A-Award | 40,000 | $68K |
| 2026-06-26 | Menzel Garry E | A-Award | 40,000 | $68K |
| 2026-06-26 | Raman Prakash | A-Award | 40,000 | $68K |
| 2026-06-26 | Dhingra Kapil | A-Award | 40,000 | $68K |
| 2026-06-26 | Campbell Shannon | A-Award | 40,000 | $68K |
| 2026-06-19 | Behbahani Ali | A-Award | 8,961 | $15K |
| 2026-06-19 | Raman Prakash | A-Award | 7,907 | $13K |
| 2026-03-20 | Behbahani Ali | A-Award | 6,919 | $15K |
| 2026-03-20 | Raman Prakash | A-Award | 6,105 | $13K |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $7.9M | $51.7M | $154.7M | $34.6M | $65.8M | $34.3M | $56.2M | $36.4M | $21.0M |
| Inversiones a Corto | 0 | 0 | 0 | $280.5M | $144.0M | $88.5M | $75.2M | $62.1M | $107.7M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $7.9M | $51.7M | $155.7M | $319.6M | $215.7M | $127.7M | $134.0M | $101.2M | $132.4M |
| Inmovilizado Material | $102000 | $134000 | $164000 | $8.8M | $30.7M | $27.4M | $23.7M | $20.4M | $9.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $8.0M | $51.8M | $158.3M | $329.7M | $247.7M | $156.3M | $158.6M | $122.6M | $143.0M |
| Cuentas por Pagar | $152000 | $416000 | $2.0M | $2.5M | $4.1M | $1.9M | $2.3M | $4.0M | $579000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.2M | $2.6M | $4.9M | $14.2M | $23.6M | $15.3M | $19.6M | $20.6M | $15.7M |
| Deuda a Largo | 0 | $60.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $14.7M | $67.4M | $205.5M | $21.9M | $51.8M | $40.6M | $41.8M | $39.4M | $30.8M |
| Reservas | -$6.8M | -$15.7M | -$51.0M | -$118.2M | -$243.8M | -$335.0M | -$417.4M | -$487.1M | -$464.7M |
| Patrimonio Neto | -$6.7M | -$15.5M | -$47.2M | $307.8M | $195.9M | $115.7M | $116.7M | $83.3M | $112.2M |
| Deuda Total | $12.5M | $60.8M | 0 | $8.7M | $28.5M | $28.1M | $25.3M | $22.2M | $18.8M |
| Deuda Neta | $4.6M | $9.1M | -$154.7M | -$306.3M | -$181.3M | -$94.7M | -$106.1M | -$76.4M | -$109.9M |
| Capital Circulante | $5.7M | $49.1M | $150.9M | $305.3M | $192.1M | $112.4M | $114.4M | $80.6M | $116.7M |
Salud financiera
| Deuda / Patrimonio | 0.18 |
| Ratio corriente | 7.28 |
Rentabilidad
| Rentabilidad sobre capital | -38.80% |
| Rentabilidad sobre capital invertido | -45.91% |
| Rentabilidad sobre activos | -34.04% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: AARD · ABEO · AVTX · CRBU · ENTA · FENC · FHTX
Explorar sector: Healthcare · Biotechnology
Más secciones de BDTX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones